These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16311657)

  • 1. Significance of anti-glomerular basement membrane antibodies in type 2 diabetic patients.
    Noorwali A
    Saudi Med J; 2005 Nov; 26(11):1734-6. PubMed ID: 16311657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of anti-glomerular basement membrane antibodies in type 2 diabetic patients.
    Aziz KA
    Saudi Med J; 2006 Jun; 27(6):915. PubMed ID: 16758072
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cytokines in noninvasive diagnostics of diabetic nephropathy progression].
    Senatorski G; Paczek L; Kropiewnicka E; Bartłomiejczyk I
    Pol Merkur Lekarski; 2002 Nov; 13 Suppl 1():28-32. PubMed ID: 12621778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating antibodies recognising oxidatively-modified low-density lipoproteins in patients with IgA nephropathy, membranous glomerulonephritis and focal glomerulosclerosis.
    Fornasieri A; Perugini C; Seccia M; Napodano P; D'Amico G; Bellomo G
    J Nephrol; 2002; 15(4):349-57. PubMed ID: 12243363
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Levels of epitope-specific autoantibodies correlate with renal damage in anti-GBM disease.
    Yang R; Hellmark T; Zhao J; Cui Z; Segelmark M; Zhao MH; Wang HY
    Nephrol Dial Transplant; 2009 Jun; 24(6):1838-44. PubMed ID: 19151145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B; Hugo CP; Hausknecht B; Boehmer KP; Riess RH; Schmieder RE
    Nephrol Dial Transplant; 2008 Apr; 23(4):1346-54. PubMed ID: 18065828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Avidity of anti-glomerular basement membrane autoantibodies was associated with renal pathological damage].
    Cui Z; Zhao MH
    Zhonghua Yi Xue Za Zhi; 2005 Apr; 85(13):903-7. PubMed ID: 16029529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Avidity of anti-glomerular basement membrane autoantibodies was associated with disease severity.
    Cui Z; Zhao MH
    Clin Immunol; 2005 Jul; 116(1):77-82. PubMed ID: 15925834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does losartan (Cozaar) slow the progression of renal disease in patients with type 2 diabetes and nephropathy?
    Pierce HL; Stevermer JJ
    J Fam Pract; 2001 Dec; 50(12):1083. PubMed ID: 11742614
    [No Abstract]   [Full Text] [Related]  

  • 11. High levels of circulating interleukin-10 in diabetic nephropathy patients.
    Myśliwska J; Zorena K; Semetkowska-Jurkiewicz E; Rachoń D; Suchanek H; Myśliwski A
    Eur Cytokine Netw; 2005 Jun; 16(2):117-22. PubMed ID: 15941682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A study on nephropathy in type 2 diabetes mellitus: histology and its correlation with clinical and biochemical parameters.
    Bhattacharya S; Mandal SK; Bandyopadhyay R; Chakrabarti S; Basu AK; Pal S
    J Indian Med Assoc; 2007 Oct; 105(10):592, 594-6. PubMed ID: 18383954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Podocyte detachment and reduced glomerular capillary endothelial fenestration in human type 1 diabetic nephropathy.
    Toyoda M; Najafian B; Kim Y; Caramori ML; Mauer M
    Diabetes; 2007 Aug; 56(8):2155-60. PubMed ID: 17536064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Concomitant macro and microvascular complications in diabetic nephropathy.
    Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
    Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy.
    Sawai K; Mukoyama M; Mori K; Yokoi H; Koshikawa M; Yoshioka T; Takeda R; Sugawara A; Kuwahara T; Saleem MA; Ogawa O; Nakao K
    Nephrol Dial Transplant; 2006 Sep; 21(9):2472-7. PubMed ID: 16820374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
    Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
    J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-GBM nephritis complicating diabetic nephropathy.
    Curioni S; Ferrario F; Rastaldi MP; Colleoni N; Colasanti G; D'Amico G
    J Nephrol; 2002; 15(1):83-7. PubMed ID: 11936433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early detection of endothelial dysfunction and early therapeutic correction effectively restore renal function in type 2 diabetic nephropathy.
    Futrakul N; Butthep P
    Ren Fail; 2005; 27(4):493-4. PubMed ID: 16060141
    [No Abstract]   [Full Text] [Related]  

  • 20. A study of plasma alpha-2-macroglobulin levels in type 2 diabetic subjects with microalbuminuria.
    Ahmad J; Singh M; Saleemuddin M
    J Assoc Physicians India; 2001 Nov; 49():1062-5. PubMed ID: 11868856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.